Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
life sciences
national blog main
boston blog main
cancer
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
adaptive biotechnologies
alector
allergan
alprazolam
american cancer society
apollomics
avelumab
bernie sanders
beta bionics
big pharma
bill & melinda gates foundation trust
biovex
black diamond therapeutics
boehringer ingelheim
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
bristol-myers squibb
cancer drugs
cgrp inhibitors
checkpoint inhibitor
chemotherapy
chronic migraine
city hill ventures
What
pharmaceutical
3
×
bio
cancer
eli
giant
acute
addresses
appetite
approval
approved
black
bread
butter
buyout
cash
causes
combo
companies
condition
dating
decades
diabetes
diamond’s
drug
drugs
fda
friday
game
giving
grabbed
happening
hasn’t
hold
immunotherapies
kgaa
lasmiditan
lilly
lilly's
lilly’s
lost
Language
unset
Current search:
amgen
×
pharmaceutical
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
